National Advisory Group on Standards and Practice Guidelines for Parenteral Nutrition: Safe practices for parenteral nutrition formulations. JPEN J Parenter Enteral Nutr. 1998;22:49–66.
2.
O'NealBCSchneiderPJPedersenCAMirtalloJM. Compliance with safe practices for preparing parenteral nutrition formulations. Am J Health-Syst Pharm. 2002;59:264–269.
3.
A.S.P.E.N. Board of Directors and The Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002;26 (Suppl):1SA–138SA. (Errata:2002;26:144).
4.
Food and Drug Administration. Safety Alert: Hazards of precipitation associated with parenteral nutrition. Am J Hosp Pharm.1994;51:1427–1428.
5.
CareyLCHaffeyM.Incident: Home TPN formula order misinterpreted after hospital admission. Home Care Highlights. 1995; (spring):7.
AliAWalentikCMantychGJSadiqHFKeenanWJNoguchiA.Iatrogenic acute hypermagnesemia after total parenteral nutrition infusion mimicking septic shock syndrome: Two case reports. Pediatrics. 2003;112(1 Pt 1):e70–e72.
12.
The U.S. Pharmacopeia Center for the Advancement of Patient Safety medication error reporting programs—MEDMARXSM and the Medication Errors Reporting Program.
13.
PetrosWPShankWA. A standardized parenteral nutrition solution: Prescribing, use, processing, and material cost implications. Hosp Pharm. 1986;21:648–656.
14.
MitchellKAJonesEAMeguidMMCurtasS.Standardized TPN order form reduces staff time and potential for error. Nutrition. 1990;6:457–460.
15.
CerraFB. A standardized TPN order form reduces staff time and potential for error [editorial]. Nutrition. 1990;6:498–499.
16.
PottsTDMonheimH.Standard total parenteral nutrition and peripheral venous nutrition forms. Hosp Pharm. 1980;15:511–514.
17.
LewisJS. Drafting a parenteral nutrition order form utilizing a physician assessment process. Military Med. 1993;158:548–552.
18.
WrightBTRobinsonLA. A simplified TPN order form. Nutr Supp Serv. 1981;1:36, 39–41.
19.
FoulksCJKrenekGMaxwellK.The effect of changing the total parenteral nutrition order form on resident physician ordering behavior. Nutr Clin Pract. 1997;12:30–34.
20.
CarmodyGHickmanREO'DellKA. Order form improves documentation of administered TPN solutions. Am J Hosp Pharm. 1986;43:594, 596, 606.
21.
RobertsMJTeasleyKMRobertsAW. Pharmacy program to reduce parenteral nutrition costs. Am J Hosp Pharm. 1981;38:1519–1520.
22.
FogelRSO'BrienJMKayBGBalasAZ. Try this simple TPN order form. Nursing. 1987;Mar:58–59.
23.
MaswosweJJNewcomerDRQuandtCM. Achieving parenteral nutrition cost savings through prescribing and formulary restrictions. Am J Hosp Pharm. 1987;44:1376–1381.
24.
LustigA.Medication error prevention by pharmacists — An Israeli solution. Pharm World Sci. 2000;22:21–25.
HicksRWCousinsDDWilliamsRL. Summary of the information submitted to MEDMARX in the year 2002: The quest for quality. USP Center for the Advancement of Patient Safety2003. Rockville, MD.
27.
National Coordinating Council recommends ways to reduce verbal order errors. NCC MERP press release, May 21, 2001.
28.
ISMP list of error-prone abbreviations, symbols, and dose designations. ISMP Medication Safety Alert. 2003;8:3–4.
29.
It doesn't pay to play the percentages. ISMP Medication Safety Alert. 2002;7(21):1–2.
30.
CareyLCHaffeyM.Incident: Home TPN formula order misinterpreted after hospital admission. Home Care Highlights. 1995; Spring:7.
31.
DriscollDFBhargavaHNLiLZaimRHBabayanVKBistrianBR. Physicochemical stability of total nutrient admixtures. Am J Health-Syst Pharm. 1995;52:623–634.
32.
Food and Drug Administration. Safety Alert: Hazards of precipitation associated with parenteral nutrition. Am J Hosp Pharm. 1994;51:1427–1428.
33.
MirtalloJM. Cost effectiveness of nutrition therapy. IN TorosianMH, ed. Nutrition for the Hospitalized Patient. Basic Science and Principles of Practice. New York, NY: Marcel Decker, Inc; 1995:653–667.
34.
MillerAS. Pharmacy issues: Total parenteral nutrition. Hosp Pharm. 2001;36:437–442.
35.
O'NealBCSchneiderPJPedersenCAMirtalloJM. Compliance with safe practices for preparing parenteral nutrition formulations. Am J Health-Syst Pharm. 2002;59:264–269.
36.
CareyLCHaffeyM.Incident: Home TPN formula order misinterpreted after hospital admission. Home Care Highlights. 1995; (spring):7.
37.
MirtalloJMJozefzcyckKGHaleKMGrauerDWEbbertMLFabriPJ. Providing 24-hour nutrient infusions to critically ill patients. Am J Hosp Pharm. 1986;43:2205–2208.
38.
SaltzmanEShahAObesityShikora S. in GottschlichMM, ed. The Science and Practice of Nutrition Support: A Case-Based Core Curriculum. Silver Spring, MD: A.S.P.E.N.; 2001:677–699.
39.
BarakMWall-AlonsoESitrinMD. Evaluation of stress factors and body weight adjustments currently used to estimate energy expenditure in hospitalized patients. JPEN J Parenter Enteral Nutr. 2002;26:231–238.
40.
GlynnCCGreeneGWWinklerMFAlbinaJE. Predictive versus measured energy expenditure using limits-of-agreement analysis in hospitalized, obese patients. JPEN J Parenter Enteral Nutr. 1999;23:147–154.
41.
ChobanPSFlancbaumL.Nourishing the obese patient. Clin Nutr. 2000;19:305–311.
42.
A.S.P.E.N. Board of Directors and The Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002;26(Suppl 1):1SA–138SA. (Errata: 2002;26:144).
43.
DelafosseBVialeJPTissotSEffects of glucose-to-lipid ratio and type of lipid on substrate oxidation rate in patients. Am J Physiol. 1994;267(5 Part 1):E775–E780.
44.
SteginkLDFreemanJBWispsJConnorWE. Absence of biochemical symptoms of essential fatty acid deficiency in surgical patients undergoing protein sparing therapy. Am J Clin Nutr. 1977;30:388–393.
45.
DickersonRNRosatoEFMullenJL. Net protein anabolism with hypocaloric parenteral nutrition in obese stressed patients. Am J Clin Nutr. 1986;44:747–755.
46.
MascioliEALopesSMChampagneCDriscollDF. Essential fatty acid deficiency and home total parenteral nutrition patients. Nutrition. 1996;12:245–249.
47.
PressMHartopPJProtteyC.Correction of essential fatty acid deficiency in man by cutaneous application of sunflower seed oil. Lancet. 1974;1:597–599.
48.
MillerDGWilliamsSKPalomboJDGriffinREBistrianBRBlackburnGL. Cutaneous application of safflower oil in preventing essential fatty acid deficiency in patients on home parenteral nutrition. Am J Clin Nutr. 1987;46:419–423.
49.
McEvoyGK (ed). American Hospital Formulary Service (AHFS) Drug Information. Bethesda, MD: American Society of Health-System Pharmacists Inc; 2003.
50.
Federal Register. 2000; 65:21200–21201.
51.
American Medical Association Department of Foods and Nutrition. Guidelines for essential trace element preparations for parenteral use. A statement by an expert panel. JAMA. 1979;241:2051–2054.
52.
FlemingCR. Trace element metabolism in adult patients requiring total parenteral nutrition. Am J Clin Nutr. 1989;49:573–579.
53.
Pluhator-MurtonMMFedorakRNAudetteRJMarriageBJYatscoffRWGramlichLM. Trace element contamination of total parenteral nutrition. 1. Contribution of component solutions. JPEN J Parenter Enteral Nutr. 1999;23:222–227.
54.
KumpfVJ. Update on parenteral iron therapy. Nutr Clin Pract. 2003;18:318–326.
55.
HollidayMASegerWE. The maintenance need for water in parenteral fluid therapy. Pediatrics. 1957;19:823–832.
56.
FitzgeraldKAMacKayMW. Calcium and phosphate solubility in parenteral nutrient solutions containing TrophAmine. Am J Hosp Pharm. 1986;43:88–93.
57.
EggertLDRishoWJMacKayMWChanGM. Calcium and phosphorus compatibility in parenteral nutrition solutions for neonates. Am J Hosp Pharm. 1982;39:49–53.
58.
HelmsRStormMCChristensenMLHakEBChesneyRW. Cysteine supplementation results in normalization of plasma concentrations in children receiving home parenteral nutrition. J Pediatr. 1999;134:358–361.
59.
HaumontDDeckelbaumRJRichelleMPlasma lipid concentration in low birth weight infants given parenteral nutrition with twenty or ten percent lipid emulsion. J Pediatr. 1989;115:787–793.
60.
A.S.P.E.N. Board of Directors. Nutrition support for low-birth-weight infants. JPEN J Parenter Enteral Nutr. 1993;17(Suppl):8SA–33SA.
61.
American Academy of Pediatrics Committee on Nutrition. Nutritional needs of low-birth-weight infants. Pediatrics. 1985;76:976–986.
62.
GreenHLHambidgeKMSchanlerRTsangRC. Guidelines for the use of vitamins, trace elements, calcium, magnesium, and phosphorus in infants and children receiving total parenteral nutrition: Report of the Subcommittee on Pediatric Parenteral Nutrient Requirements from the Committee on Clinical Practice Issues of the American Society for Clinical Nutrition. Am J Clin Nutr. 1988;48:1324–1342.
63.
MoukarelAASongMKBuchmanALExcessive chromium intake in children receiving total parenteral nutrition. Lancet. 1992;339:385–388.
64.
KleinGL. Aluminum contamination of parenteral nutrition solutions and its impact on the pediatric patient. Nutr Clin Pract. 2003;18:302–307.
65.
KleinGL. Aluminum in parenteral solutions revisited—again. Am J Clin Nutr. 1995;61:449–56.
66.
KooWWKKaplanLAHornJTsangRCSteichenJJ. Aluminum in parenteral solutions-sources and possible alternatives. JPEN J Parenter Enteral Nutr. 1986;10:591–595.
67.
MillinerDSShinabergerJHShumanPCoburnJW. Inadvertent aluminum administration during plasma exchange due to aluminum contamination of albumin-replacement solutions. N Engl J Med. 1985;312:165–167.
68.
FellGSShenkinAHallsD.Aluminum contamination of intravenous pharmaceuticals, nutrients, and blood products [letter]. Lancet. 1986;1:380.
69.
Federal Register. 2000;65:4103–4111.
70.
Federal Register. 2003;68:32979–32981.
71.
HellerRMKirchnerSAO'NeillJASkeletal changes of copper deficiency in infants receiving prolonged parenteral nutrition. J Pediatr. 1978;92:947–949.
72.
RiellaMCBroviacJWWellsMScribnerBH. Essential fatty acid deficiency in human adults during total parenteral nutrition. Ann Intern Med. 1975;83:786–789.
73.
Anonymous. Death associated with thiamin deficient total parenteral nutrition. MMWR. 1987;38:43.
74.
AlliouMEhrinpreisMN. Shortage of intravenous multivitamin solution in the United States. [Letter]. N Engl J Med. 1997;337:54–55.
75.
TravisSFSugarmanHJRubergRLAlterations of redcell glycolytic intermediates and oxygen transport as a consequence of hypophosphatemia in patients receiving intravenous hyperalimentation. N Engl J Med. 1971;285:763–768.
76.
Spotlight on the key elements of the medication system. ISMP Medication Safety Alert. 2003;2:3–4.
77.
A.S.P.E.N. Board of Directors. Standards for nutrition support pharmacists. Nutr Clin Pract. 1999;14:151–162.
78.
(797) Pharmaceutical Compounding—Sterile Preparations. United States Pharmacopeial Convention, Pharmacopeial Forum2003;29:940–965.
79.
American Society for Health-System Pharmacists, ASHP Guidelines on Safe Use of Automated Compounding Devices for the Preparation of Parenteral Nutrition Admixtures. Am J Health-Syst Pharm. 2000;57:1343–1348.
80.
American Society for Health-System Pharmacists, ASHP. Guidelines on quality assurance for pharmacy-prepared sterile products. Am J Health-Syst Pharm. 2000;57:1150–1169.
81.
BozettiFBonfantiGRegaliaECalligarisLCozzaglioL.Catheter sepsis from infusate contamination. Nutr Clin Pract. 1990;5:156–159.
82.
HowardLChuRFemanSMintzHOvesenLWolfB.Vitamin A deficiency from long-term parenteral nutrition. Ann Intern Med. 1980;93:576–577.
83.
GuptaVD. Stability of vitamins in total parenteral nutrient solutions. Am J Hosp Pharm. 1986;43:2132.
84.
DriscollDFBhargavaHNLiLPhysicochemical stability of total nutrient admixtures. Am J Hosp Pharm. 1995;52:623–634.
85.
DriscollDF. Total nutrient admixtures: Theory and practice. Nutr Clin Pract. 1995;10:114–119.
86.
DriscollDFBaptistaRJMitranoFPParenteral nutrient admixtures as drug vehicles. Theory and practice in the critical care setting. Ann Pharmacother. 1991;25:276–283.
87.
Van den BergGWoutersPWeekersFIntensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–1367.
88.
McMahonMMRizzaRA. Nutrition support in hospitalized patients with diabetes mellitus. Mayo Clinic Proc. 1996;71:587–594.
89.
RosmarinDKWardlawGMMirtalloJ.Hyperglycemia associated with high continuous infusion rates of total parenteral nutrition dextrose. Nutr Clin Pract. 1996;11:151–156.
90.
McCowenKCMalhotraABistrianBR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17:107–124.
91.
BoordJBGraberALChristmanHWPowersAC. Practical management of diabetes in critically ill patients. Am J Respir Crit Care Med. 2001;164:1763–1767.
92.
TrisselLAGilbertDLMartinezJFBakerMBWalterWVMirtalloJM. Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm. 1997;54:1295–1300.
93.
TrisselLAGilbertDLMartinezJFBakerMBWalterWVMirtalloJM. Compatibility of medications with 3-in-1 parenteral nutrition admixtures. JPEN J Parenter Enteral Nutr. 1999;23:67–74.
94.
A.S.P.E.N. Board of Directors and the Clinical Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002;26 (Suppl):1SA–138SA (Errata: 2002;26:114).
Centers for Disease Control and Prevention. Guidelines for the Prevention of Intravascular Catheter-Related Infections. MMWR. 2002;51:RR–10.
97.
SteigerE.Obtaining and Maintaining Vascular Access in the Home Parenteral Nutrition Patient. JPEN J Parenter Enteral Nutr. 2002;26(Suppl 5):S17–S20.
98.
KrzywdaEAAndrisDAEdmistonCEWallaceJR. Parenteral access devices. IN GottschlichMM, ed. The Science and Practice of Nutrition Support: A Case-Based Care Curriculum. Dubuque, LA: American Society for Parenteral and Enteral Nutrition, Kendall/Hunt; 2001:225–250.
CollierPEGoodmanGB. Cardiac tamponade caused by central venous catheter perforation of the heart: A preventable complication. J Am Coll Surg. 1995;181:459–463.
101.
IsaacsJWMillikanWJStackhouseJHershTRudmanD.Parenteral nutrition of adults with 900-milliosmolar solution via peripheral vein. Am J Clin Nutr. 1977;30:552–559.
102.
HardenJLKempCMirtalloJ.Femoral catheters increase risk of infection in total parenteral nutrition patients. Nutr Clin Pract. 1995;10:60–66.
103.
BethuneKAllwoodMGraingerCWormleightonC.British Pharmaceutical Nutrition Group Working Party. Use of filters during the preparation and administration of parenteral nutrition: Position paper and guidelines prepared by a British pharmaceutical nutrition group working party. Nutrition. 2001;17:403–408.
104.
National Advisory Group on Standards and Practice Guidelines for Parenteral Nutrition: Safe Practices for Parenteral Nutrition Formulations. JPEN J Parenter Enteral Nutr. 1998;22:49–66.
105.
Food and Drug Administration, Safety Alert: Hazardous of Precipitation Associated with Parenteral Nutrition. Am J Hosp. Pharm. 1994;51:1427–1428.
106.
DickersonRN. Di (2-ethylhexyl) phthalate as a plasticizer for intravenous bags and tubing: A toxicological quandary. Nutrition. 1997;13:1010–1012.
U.S. Department of Health and Human Services, Public Health Service Centers for Disease Control and Prevention (CDC), National Institute for Occupational Safety and Health Settings (NIOSH). Preventing Needlestick Injuries in Health Settings. NIOSH Publication No. 2000–108. Cincinnati, OH: NIOSH; November 1999.
109.
U.S. Department of Labor, Occupational Safety and Health Administration (OSHA). Enforcement Procedures for the Occupational Exposure to Bloodborne Pathogens. Directives No. CPL 2–2. 44D. Effective Date: November 5, 1999.
110.
U.S. Department of Labor, Occupational Safety and Health Administration (OSHA). Occupational Exposure to Bloodborne Pathogens; Needlesticks and Other Sharp Injuries; Final Rule Federal Legislation, Public Law 106–430. Effective Date: April 18, 2001.
111.
BarberJRMillerSJSacksGS. Parenteral feeding formulations. IN GottschlichMM, ed. The Science and Practice of Nutrition Support: A Case-Based Care Curriculum. Dubuque, IA: American Society for Parenteral and Enteral Nutrition, Kendall/Hunt; 2001:251–268.
112.
RollinsCJ. Total nutrient admixtures: Stability issues and their impact on nursing practice. J Intraven Nurs. 1997;6:299–304.
113.
StrausbergKM. Parenteral nutrition admixture. IN MerrittRJ, ed. A.S.P.E.N. Nutrition Support Manual. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition; 1998:8–1–8–12.
114.
KumpfVJGervasioJ.Pharmacotherapeutics. IN GottschlichMM, ed. The Science and Practice of Nutrition Support: A Case-Based Care Curriculum. Dubuque, IA: American Society for Parenteral and Enteral Nutrition, Kendall/Hunt; 2001:287–299.
115.
KlangMGHayesEMBlossCS. Drug-nutrient considerations-parenteral nutrition. IN MerrittRJ, ed. A.S.P.E.N. Nutrition Support Practice Manual. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition; 1998:10–1–10–11.
116.
TrisselLAGilbertDLMartinezJFBakerMBWalterWVMirtalloJM. Compatibility of medications with 3-in-1 parenteral nutrition admixtures. JPEN J Parenter Enteral Nutr. 1999;23:67–74.
117.
SacksGSDriscollDF. Does lipid hang time make a difference? Time is of the essence. Nutr Clin Pract. 2002;17:284–290.
118.
CurryCRQuiePG. Fungal septicemia in patients receiving parenteral hyperalimentation. N Engl J Med. 1971;285:1221–1225.
119.
DanknerWMSpectorSAFiererJDavisCE. Malassezia fungemia in neonates and adults: Complications of hyperalimentation. Rev Infect Dis. 1987;9:743–753.
120.
WeissSJSchochPEBurkeAC. Malassezia furfur fungemia associated with central venous catheter lipid emulsion infusion. Heart Lung. 1991;20:87–90.
121.
OkekeCCBaileyLMedwickTGradyLT. Revised USP standards for product dating, packaging, and temperature monitoring. Am J Health-Syst Pharm. 2000;57:1441–1445.
122.
A.S.P.E.N. Board of Directors, Clinical Pathways and Algorithms for Delivery of Parenteral and Enteral Nutrition in Adults. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition; 1998.
123.
CarpentierYAKinneyJMSidedrovaVSHypertriglyceridemic clamp: A new model for studying lipid metabolism. Clin Nutr. 1990;9(Suppl 1):1–9.
124.
SacksGSMouserJF. Is IV lipid emulsion safe in patients with hypertriglyceridemia?Nutr Clin Pract.1997;12:120–123.
125.
American Society of Hospital Pharmacists. ASHP technical assistance bulletin on hospital drug distribution and control. Am J Hosp Pharm. 1980;37:1097–1103.